EG625480 Activators
Ssxb14, a member of the SSX family, intricately navigates the landscape of gene regulation within the cellular nucleus, signifying its profound involvement in complex cellular processes. Positioned at the intersection of critical pathways, Ssxb14 emerges as a key player with orthology to human genes SSX1, SSX2B, and SSX3, reinforcing its significance in cellular homeostasis. The activation of Ssxb14 unfolds through the dynamic interplay of various chemical regulators that modulate its expression and function. Notably, inhibitors targeting specific cellular components contribute to the intricate network influencing Ssxb14. Nutlin-3 disrupts the MDM2-p53 interaction, potentially enhancing Ssxb14 expression by relieving p53-mediated repression. SAHA and Trichostatin A, as HDAC inhibitors, alter chromatin structure, impacting Ssxb14 expression by modulating histone deacetylases. JQ1, a BET inhibitor, influences gene transcription, potentially regulating Ssxb14 expression.
Moreover, the MEK inhibitor PD0325901 and PI3K inhibitor LY294002 modulate the MAPK/ERK and PI3K/Akt pathways, respectively, influencing Ssxb14 expression and cellular responses. GSK343, an EZH2 inhibitor, regulates histone methylation, potentially affecting Ssxb14 expression. The p300/CBP inhibitor C646 modulates gene transcription, contributing to the intricate regulatory landscape of Ssxb14. Epigenetic modulators, including 5-Azacytidine and BIX 01294, impact DNA methylation patterns and histone methylation, respectively, potentially promoting Ssxb14 expression through alterations in epigenetic marks. Inhibitors like SB216763 targeting GSK-3 and BI-2536 targeting PLK1 present additional layers of complexity, suggesting potential crosstalk with Wnt signaling and the cell cycle, respectively. In conclusion, the multifaceted nature of Ssxb14's activation involves a delicate orchestration of chemical regulators impacting gene expression and cellular processes. The identified inhibitors provide a foundation for understanding the nuanced mechanisms governing Ssxb14, offering insights into its intricate role within the cellular nucleus and its potential implications in synovial sarcoma.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(+)-Nutlin-3 | 675576-97-3 | sc-222085 sc-222085A | 500 µg 1 mg | $94.00 $122.00 | ||
MDM2 inhibitor. Disrupts the MDM2-p53 interaction, potentially enhancing Ssxb14 expression by relieving p53-mediated repression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor. Modulates histone deacetylases, potentially promoting Ssxb14 expression by altering chromatin structure. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
BET inhibitor. Targets bromodomain-containing proteins, potentially impacting Ssxb14 expression by regulating gene transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor. Modulates the PI3K/Akt pathway, potentially impacting Ssxb14 expression and cellular responses. | ||||||
GSK343 | 1346704-33-3 | sc-397025 sc-397025A | 5 mg 25 mg | $151.00 $461.00 | 1 | |
EZH2 inhibitor. Targets enhancer of zeste homolog 2 (EZH2), potentially influencing Ssxb14 expression by regulating histone methylation. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
p300/CBP inhibitor. Modulates p300/CBP, potentially impacting Ssxb14 expression by regulating gene transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor. Influences DNA methylation patterns, potentially promoting Ssxb14 expression by altering epigenetic marks. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor. Modulates histone deacetylases, potentially promoting Ssxb14 expression by altering chromatin structure. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
GSK-3 inhibitor. Modulates glycogen synthase kinase-3, potentially influencing Wnt signaling and Ssxb14 expression. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
PLK1 inhibitor. Targets Polo-like kinase 1 (PLK1), potentially influencing Ssxb14 expression by modulating the cell cycle. | ||||||